Why Is Baudax Bio (BXRX) Stock Up 46% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Baudax Bio (BXRX) stock is rocketing higher on Friday after the pharmaceutical company initiated a Phase 2 clinical trial of BX1000. The post Why Is Baudax Bio (BXRX) Stock Up 46% Today? appeared first on InvestorPlace . More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.